Hodgkin's lymphoma Posts on Medivizor
Navigation Menu

Hodgkin’s lymphoma Posts on Medivizor

Managing patients with limited-stage Hodgkin lymphoma by brentuximab vedotin based therapy

Managing patients with limited-stage Hodgkin lymphoma by brentuximab vedotin based therapy

Posted by on Jul 5, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell The study evaluated if brentuximab-vedotin (BV; Adcetris) consolidation therapy can reduce the use of radiation therapy (RT) in patients with limited-stage (LS) Hodgkin lymphoma (HL). The authors found that BV consolidation achieved good outcomes in such patients when given after ABVD therapy. Some background HL is a cancer of the...

Read More

How does ABVD chemotherapy affect the fertility of female patients with Hodgkin lymphoma?

How does ABVD chemotherapy affect the fertility of female patients with Hodgkin lymphoma?

Posted by on Jun 27, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined if ABVD chemotherapy impacted fertility in female patients with Hodgkin lymphoma (HL). The authors found that ABVD reduced the levels of one of the fertility hormones and the type of fertility treatment patients opted for was not affected by ABVD. Some background Many patients with HL are young and fertility...

Read More

How does COVID-19 affect patients with cancer undergoing chemotherapy?

How does COVID-19 affect patients with cancer undergoing chemotherapy?

Posted by on Jun 21, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined how COVID-19 infection affects patients with cancer undergoing chemotherapy and the role of other factors in COVID-19 complications. The results showed that patients with advanced age and other medical conditions had a higher risk of COVID-19 complications but chemotherapy treatment did not need to be stopped. Some...

Read More

Impact of graft cryopreservation on allogeneic hematopoietic stem cell transplant outcomes using post-transplant cyclophosphamide

Impact of graft cryopreservation on allogeneic hematopoietic stem cell transplant outcomes using post-transplant cyclophosphamide

Posted by on Jun 21, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study aimed to compare outcomes of allogeneic hematopoietic stem cell transplant (alloHSCT) using cryopreserved (frozen) and fresh grafts in patients with blood cancers who received post-transplant cyclophosphamide (Cytoxan).   This study concluded that cryopreservation (CP) does...

Read More

Can radiotherapy benefit patients with advanced Hodgkin lymphoma with small tumors?

Can radiotherapy benefit patients with advanced Hodgkin lymphoma with small tumors?

Posted by on Jun 13, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined if radiotherapy (RT) would benefit patients with advanced Hodgkin lymphoma (HL) with small tumors following chemotherapy. The authors found that RT may increase patients’ survival without worsening of HL, although this may also increase side effects. Some background Treatment options for patients with...

Read More

Which is the more effective and safer chemotherapy option for patients with advanced Hodgkin lymphoma?

Which is the more effective and safer chemotherapy option for patients with advanced Hodgkin lymphoma?

Posted by on Jun 7, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study compared the effectiveness and safety of ABVD and BEACOPP chemotherapy for patients with advanced Hodgkin lymphoma (HL). The authors found that while BEACOPP was more effective in the short term, ABVD was as effective in the long term and safer for patients. Some background Chemotherapy is the standard initial treatment...

Read More

Update regarding the treatment options for patients with Hodgkin lymphoma

Update regarding the treatment options for patients with Hodgkin lymphoma

Posted by on Jun 6, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This article reviewed the current treatment options for patients with Hodgkin lymphoma (HL). Some background Treatment options for patients with HL depend on the type of HL, stage of the disease, and the presence of risk factors. The stage of HL represents how widespread or severe the cancer is. Risk factors indicate that there...

Read More

How do other serious health conditions affect diagnosis and treatment for older patients with Hodgkin lymphoma?

How do other serious health conditions affect diagnosis and treatment for older patients with Hodgkin lymphoma?

Posted by on May 17, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined older patients with Hodgkin lymphoma (HL) to understand how other serious health conditions affect their diagnosis and treatment. The authors found that patients with more serious illnesses were more likely to be diagnosed with advanced HL and had limited treatment options. Some background Treatment options for...

Read More

Long-term outcomes of brentuximab vedotin with chemotherapy for patients with advanced classical Hodgkin lymphoma

Long-term outcomes of brentuximab vedotin with chemotherapy for patients with advanced classical Hodgkin lymphoma

Posted by on May 17, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study compared ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) and brentuximab vedotin (Adcedris; A) + AVD (doxorubicin, vinblastine, and dacarbazine) chemotherapy combinations to understand which is more effective long term for patients with advanced classical Hodgkin lymphoma (HL). The authors concluded...

Read More

How can PET scans be used to predict treatment results for older patients with Hodgkin lymphoma?

How can PET scans be used to predict treatment results for older patients with Hodgkin lymphoma?

Posted by on May 17, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study compared ways to interpret PET scans to see which best predicted treatment results for older patients with Hodgkin lymphoma (HL). The authors identified several methods of PET scan analysis that were able to predict how effective treatment was for these patients. Some background PET scans are often used to diagnose...

Read More

Which low-intensity chemotherapy is most effective for patients with classical Hodgkin lymphoma receiving stem cell transplantation?

Posted by on May 10, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study compared the effectiveness of three low-intensity chemotherapy combinations to treat patients with classical Hodgkin lymphoma (HL) following stem cell transplantation (SCT). There were no significant differences between the three chemotherapy types in terms of patients’ survival and relapse. Some background...

Read More